Quidel (NASDAQ:QDEL) is a renowned diagnostic healthcare manufacturer focused on developing and producing innovative testing solutions aimed at enhancing patient outcomes and providing clinical value across various medical settings. Their portfolio covers a broad range of products intended for the diagnosis and monitoring of critical diseases and conditions, ranging from infectious diseases to cardiology and bone health. Quidel is known for its rapid diagnostic tests, including point-of-care tests that deliver quick and accurate results, facilitating timely treatment decisions. With a commitment to research and development, Quidel aims to advance medical diagnostics through continuous innovation, striving to meet the evolving healthcare needs of communities worldwide. Their mission revolves around empowering healthcare professionals with reliable, accessible, and easy-to-use diagnostic tools that can significantly impact patient care.